Title21 Health Solutions, a leading provider of enterprise quality management systems and cell and gene therapy orchestration platforms, announces the acquisition of MyCellHub and its advanced manufacturing execution system (MES) platform, expanding its ability to connect the advanced therapies ecosystem through cutting-edge digital solutions. The MES technology is specifically designed to meet the stringent requirements of the healthcare, biotech, and cell therapy sectors by delivering real-time production monitoring, digital batch record management, and embedded quality management within manufacturing operations.
Read the full article: Title21 Health Solutions Acquires MyCellHub to Expand Digital Capabilities in Life Sciences and Advanced Therapies //
Source: https://www.einpresswire.com/article/880580903/title21-health-solutions-acquires-mycellhub-to-expand-digital-capabilities-in-life-sciences-and-advanced-therapies